Skip to main content
Livermore
Livermore
ZHEN

Daiwa Securities Group Inc.

SEC CIK
0001481045
Latest filing
Jul 31, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Daiwa Securities Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ARWR by Daiwa Securities Group Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−1,377−100.0%Sold outHolders
Q4 20251,377$91.0K<0.1%−2,427−63.8%ReducedHolders
Q3 20253,804$131.0K<0.1%−385−9.2%ReducedHolders
Q2 20254,189$66.0K<0.1%+3,763+883.3%AddedHolders
Q1 2025426$5.00K<0.1%00.0%UnchangedHolders
Q4 2024426$8.00K<0.1%00.0%UnchangedHolders
Q3 2024426$8.00K<0.1%00.0%UnchangedHolders
Q2 2024426$11.0K<0.1%00.0%UnchangedHolders
Q1 2024426$12.0K<0.1%00.0%UnchangedHolders
Q4 2023426$13.0K<0.1%00.0%UnchangedHolders
Q3 2023426$11.0K<0.1%00.0%UnchangedHolders
Q2 2023426$15.0K<0.1%00.0%UnchangedHolders
Q1 2023426$11.0K<0.1%00.0%UnchangedHolders
Q4 2022426$17.0K<0.1%+32+8.1%AddedHolders
Q3 2022394$13.0K<0.1%00.0%UnchangedHolders
Q2 2022394$14.0K<0.1%+89+29.2%AddedHolders
Q1 2022305$14.0K<0.1%00.0%UnchangedHolders
Q4 2021305$20.0K<0.1%−52−14.6%ReducedHolders
Q3 2021357$22.0K<0.1%+151+73.3%AddedHolders
Q2 2021206$17.0K<0.1%00.0%UnchangedHolders
Q1 2021206$14.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.